Detection of human papilloma virus in women attending the IRCCS , Ospedale oncologico Bari, Southern Italy: Preliminary data

New Microbiologica

Volumn 29, Issue 1, 2006, Pages 69-73

  Crapolicchio, Antonella ^a   Simone, Giovanni ^a   Caponio, Maria Angela ^a   Fumarola, Luciana ^b   Monno, Rosa ^b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

HPV; HPV genotypes; Morphological abnormalities

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHEMISTRY; CYTOCHEMISTRY; DNA SEQUENCE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ITALY; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 33645555133     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ADAM, E., BERKOVA, Z., DAXNEROVA, Z., ICENOGLE, J., REEVES, W.C., KAUFMAN, R.H. (2000). Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease. Am J Obstet Gynecol, 182, 257-64.
2. ANHANG, R, GOODMAN, A., GOLDIE, S.J. (2004). HPV Communication: review of existing research and recommendations for patient education. Cancer J Clin, 54, 248-259.
3. BURD, E.M. (2003). Human papillomavirus and cervical cancer. Clin Microbiol Rev 16, 1-17.
4. CHEW G.K., CRUICKSHANK M.E., ROONEY P.H., MILLER I.D., PARKIN D.E., MURRAY G.I. (2005). Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer, Online ISSN: 1532-1827.
5. DE VILLIERS, E.M., FAUQUET, C., BROKER, T.R., BERNARD, H.U., ZUR HAUSEN, H. (2004). Classification of papillomaviruses. Virology, 324; 17-27.
6. EVANDER, M., EDLUND, K., GUSTAFSSON, A., JONSSON, M., KARLSSON, R., RYLANDER, E., WADELL, G. (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis, 171; 1026-1030.
7. GRAVTTT, P.E., PEYTON, C.L., APPLE, R.J., WHEELER, C.M. (1998). Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol, 36; 3020-3027.
8. HARRO, C.D., PANG, Y.Y., RODEN, R.B., HILDESHEIM, A., WANG, Z., REYNOLDS, M.J., MAST, T.C., ROBINSON, R., MURPHY, B.R., KARRON, R.A., DILLNER, J., SCHILLER, J.T., LOWY, D.R. (2001). Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst, 93; 284-292.
9. JUNG, W.W., CHUN, T., SUL, D., HWANG, K.W., KANG, H.S., LEE, D.J., HAN, I.K. (2004). Strategies against human papillomavirus infection and cervical cancer. J. Microbiol, 42; 255-266.
10. KAHN, J.A., HILLARD, P.A. (2004) Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin, 15; 301-321.
11. KAY, P., ALLAN, B., DENNY, L., HUFFMAN, M., WILLIAMSON, A.L. (2005). Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol, 75; 435-439.
12. KJAER, S.K., VAN DEN BRULE, A.J., BOCK, J.E, POLL, P.A., ENGHOLM, G., SHERMAN, M.E., WALBOOMERS, J.M., MEIJER, C.J. (1996). Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer, 65; 601-606.
13. KLETER, B., VAN DOORN, L.J., TER SCHEGGET, J., SCHRAUWEN, L., VAN KRIMPEN, K., BURGER, M., TER HARMSEL, B., QUINT, W. (1998). Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol, 153; 1731-1739.
14. MOLIJN, A., KLETER, B., QUINT, W., VAN DOORN, L.J. (2005). Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol, 32; 43-51.
15. MUNOZ, N. (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19; 1-5.
16. QUINT, W.G.V., SCHOLTE, G., VAN DOORN, L.J., KLETER, B., SMITS, P.H.M., LINDEMAN, J. (2001). Comparative analysis of Human Papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV Genotyping. J Pathol, 194, 154-158.
17. RICHART, R.M. (1980). The patient with an abnormal Pap smear-screening techniques and management. N Engl J Med, 302, 332-334.
18. RODEN, R.B., LOWY, D.R., SCHILLER, J.T. (1997). Papillomavirus is resistant to desiccation. J Infect Dis, 176; 1076-1079.
19. SPANO, J.P., MARCELIN, A.G., CARCELIN, G. (2005). HPV and cancer. Bull Cancer 92, 59-64.
20. SOLOMON, D., DAVEY, D., KURMAN, R., MORIARTY, A., O'CONNOR, D., PREY, M., RAAB, S., SHERMAN, M., WILBUR, D., WRIGHT, T. JR, YOUNG, N. (2002). The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9.
21. VAN DOORN, L.J., QUINT, W., KLETER, B., MOLIJN, A., COLAU, B., MARTIN, M.T., KRAVANG-In, TORREZ-MARTINEZ, n., PEYTON, C.L., WHEELER, M.C. (2002). Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF10 Line Probe Assay. J Clin Microbiol, 40, 979-83.
22. VOLPERS, C., AND STREEK R.E. (1991). Genome organization and nucleotide sequence of human papillomavirus type 39. Virology 181, 419-423.
23. ZHANG, L.F., ZHOU, J., CHEN, S., CAI, L.L., BAO, Q.Y., ZHENG, F.Y., Lu, J.Q., PADMANABHA, J., HENGST, K., MALCOLM, K., FRAZER, I.H. (2000). HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine, 18, 1051-8.